Caribou Biosciences reports durable responses for CB-011 therapy
Go back to Caribou Biosciences reports durable responses for CB-011 therapy| (NASDAQ: CRBU) | Delayed: 1.63 -0.03 (1.81%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.66 | 52 Week High | $ | |||
| Open | $1.62 | 52 Week Low | $ | |||
| Day High | $1.65 | P/E | N/A | |||
| Day Low | $1.60 | EPS | $ | |||
| Volume | 824,435 | |||||
